Cassava Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. 

CEO
Richard Jon Barry
CEORichard Jon Barry
Employees
30
Employees30
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
1998
Founded1998
Employees
30
Employees30

SAVA Key Statistics

Market cap
101.45M
Market cap101.45M
Price-Earnings ratio
-0.85
Price-Earnings ratio-0.85
Dividend yield
Dividend yield
Average volume
485.57K
Average volume485.57K
High today
$2.17
High today$2.17
Low today
$2.10
Low today$2.10
Open price
$2.15
Open price$2.15
Volume
469.70K
Volume469.70K
52 Week high
$33.98
52 Week high$33.98
52 Week low
$1.15
52 Week low$1.15

SAVA News

TipRanks 2d
Cassava Sciences Releases New Corporate Presentation

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own SAVA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.